278 related articles for article (PubMed ID: 14672349)
1. Deletion mutants of BMP folding variants act as BMP antagonists and are efficient inhibitors for heterotopic ossification.
Weber FE; Schmökel H; Oelgeschläger M; Nickel J; Maly FE; Hortschansky P; Grätz KW
J Bone Miner Res; 2003 Dec; 18(12):2142-51. PubMed ID: 14672349
[TBL] [Abstract][Full Text] [Related]
2. Disulfide bridge conformers of mature BMP are inhibitors for heterotopic ossification.
Weber FE; Eyrich G; Grätz KW; Thomas RM; Maly FE; Sailer HF
Biochem Biophys Res Commun; 2001 Aug; 286(3):554-8. PubMed ID: 11511095
[TBL] [Abstract][Full Text] [Related]
3. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
5. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
7. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
[TBL] [Abstract][Full Text] [Related]
8. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.
Behnam K; Murray SS; Brochmann EJ
Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749
[TBL] [Abstract][Full Text] [Related]
9. BMP responsiveness in human mesenchymal stem cells.
Diefenderfer DL; Osyczka AM; Reilly GC; Leboy PS
Connect Tissue Res; 2003; 44 Suppl 1():305-11. PubMed ID: 12952214
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening and selection of drug-like compounds to block noggin interaction with bone morphogenetic proteins.
Ahmed S; Metpally RP; Sangadala S; Reddy BV
J Mol Graph Model; 2010 Apr; 28(7):670-82. PubMed ID: 20137990
[TBL] [Abstract][Full Text] [Related]
11. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer.
Haudenschild DR; Palmer SM; Moseley TA; You Z; Reddi AH
Cancer Res; 2004 Nov; 64(22):8276-84. PubMed ID: 15548695
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
15. Coordinated expression of noggin and bone morphogenetic proteins (BMPs) during early skeletogenesis and induction of noggin expression by BMP-7.
Nifuji A; Noda M
J Bone Miner Res; 1999 Dec; 14(12):2057-66. PubMed ID: 10620065
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
17. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
18. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin.
Abe E; Yamamoto M; Taguchi Y; Lecka-Czernik B; O'Brien CA; Economides AN; Stahl N; Jilka RL; Manolagas SC
J Bone Miner Res; 2000 Apr; 15(4):663-73. PubMed ID: 10780858
[TBL] [Abstract][Full Text] [Related]
19. Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation.
van Bezooijen RL; Svensson JP; Eefting D; Visser A; van der Horst G; Karperien M; Quax PH; Vrieling H; Papapoulos SE; ten Dijke P; Löwik CW
J Bone Miner Res; 2007 Jan; 22(1):19-28. PubMed ID: 17032150
[TBL] [Abstract][Full Text] [Related]
20. Neural induction requires BMP inhibition only as a late step, and involves signals other than FGF and Wnt antagonists.
Linker C; Stern CD
Development; 2004 Nov; 131(22):5671-81. PubMed ID: 15509767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]